Drug Pipeline

Latanoprost (0.005%) Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
2
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2/3
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06666855 A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in… Open Angle Glaucoma Active, Not Recruiting
Phase 2/3
NCT07354516 Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension OAG - Open-Angle Glaucoma Recruiting
Early Phase 1
NCT07425535 Optic Nerve Head Strain in Non-glaucoma Subjects Glaucoma Not Yet Recruiting
Sponsors Running Latanoprost (0.005%) Trials
Santen Pharmaceutical Co., Ltd. (1) Qlaris Bio, Inc. (1) Johns Hopkins University (1)
Disease Areas
Hypertension (2)
Get alerts when Latanoprost (0.005%) trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free